Golimumab

Golimumab
Product Description

Golimumab is a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α), a cytokine involved in inflammatory responses. By blocking TNF-α, golimumab helps reduce inflammation and is primarily used to treat autoimmune diseases such as:

  • Rheumatoid arthritis (RA)
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Ulcerative colitis

Read more Show less

GENEXT GENOMICS PVT LTD

  • IN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
View company profile
Categories
more categories Show less
Specifications
  • Details
    GeNext Genomics has successfully developed a biosimilar clone of Golimumab, a monoclonal antibody targeting TNF-alpha, pivotal in treating autoimmune conditions. Leveraging our expertise in clone development and rigorous analytical validation, our Golimumab biosimilar clone matches the efficacy and quality attributes of the innovator. This robust, scalable clone is designed to support high-yield production, providing a cost-effective solution for healthcare providers and patients.
  • Selling Points
    Immune Health
  • Supplied from
    India
  • Measured In
    milligram
More specifications Fewer specifications

GENEXT GENOMICS PVT LTD

  • IN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
View company profile

More Products from GENEXT GENOMICS PVT LTD (1)

  • Biosimilar Clone Development Service

    Product Biosimilar Clone Development Service

    At GeNext Genomics, we specialize in end-to-end clone development for biosimilars, catering to the high demand for biologics. Utilizing advanced cell lines such as CHO GS, Expi CHO, HEK, and CHO S, we ensure high-yield, high-quality biosimilar production. Our approach includes detailed characterization and...